These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 36708953)

  • 1. Real world transcranial magnetic stimulation for major depression: A multisite, naturalistic, retrospective study.
    Bouaziz N; Laidi C; Bulteau S; Berjamin C; Thomas F; Moulier V; Benadhira R; Szekely D; Poulet E; Galvao F; Guillin O; Castillo MC; Sauvaget A; Plaze M; Januel D; Brunelin J; Rotharmel M
    J Affect Disord; 2023 Apr; 326():26-35. PubMed ID: 36708953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. rTMS of the dorsomedial prefrontal cortex for major depression: safety, tolerability, effectiveness, and outcome predictors for 10 Hz versus intermittent theta-burst stimulation.
    Bakker N; Shahab S; Giacobbe P; Blumberger DM; Daskalakis ZJ; Kennedy SH; Downar J
    Brain Stimul; 2015; 8(2):208-15. PubMed ID: 25465290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.
    Blumberger DM; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Downar J
    Lancet; 2018 Apr; 391(10131):1683-1692. PubMed ID: 29726344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of intermittent Theta Burst Stimulation (iTBS) and 10-Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant unipolar depression: study protocol for a randomised controlled trial.
    Bulteau S; Sébille V; Fayet G; Thomas-Ollivier V; Deschamps T; Bonnin-Rivalland A; Laforgue E; Pichot A; Valrivière P; Auffray-Calvier E; Fortin J; Péréon Y; Vanelle JM; Sauvaget A
    Trials; 2017 Jan; 18(1):17. PubMed ID: 28086851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similar Outcomes in Treating Major Depressive Disorder With 10 Hz Repetitive Transcranial Magnetic Stimulation (rTMS) Versus Intermittent Theta Burst Stimulation (iTBS): A Naturalistic Observational Study.
    Spitz NA; Ten Eyck P; Nizar K; Boes AD; Trapp NT
    J Psychiatr Pract; 2022 Mar; 28(2):98-107. PubMed ID: 35238821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent theta burst stimulation (iTBS) versus 10 Hz high-frequency repetitive transcranial magnetic stimulation (rTMS) to alleviate treatment-resistant unipolar depression: A randomized controlled trial (THETA-DEP).
    Bulteau S; Laurin A; Pere M; Fayet G; Thomas-Ollivier V; Deschamps T; Auffray-Calvier E; Bukowski N; Vanelle JM; Sébille V; Sauvaget A
    Brain Stimul; 2022; 15(3):870-880. PubMed ID: 35609816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of transcranial magnetic intermittent theta-burst stimulation in the treatment of depression - A Swedish register-based study.
    Ekman CJ; Popiolek K; Bodén R; Nordenskjöld A; Lundberg J
    J Affect Disord; 2023 May; 329():50-54. PubMed ID: 36841303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Health-related quality of life assessment in depression after low-frequency transcranial magnetic stimulation].
    Dumas R; Boyer L; Richieri R; Guedj E; Auquier P; Lançon C
    Encephale; 2014 Feb; 40(1):74-80. PubMed ID: 24091070
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implementation of intermittent theta burst stimulation compared to conventional repetitive transcranial magnetic stimulation in patients with treatment resistant depression: A cost analysis.
    Mendlowitz AB; Shanbour A; Downar J; Vila-Rodriguez F; Daskalakis ZJ; Isaranuwatchai W; Blumberger DM
    PLoS One; 2019; 14(9):e0222546. PubMed ID: 31513675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trajectories of Response to Dorsolateral Prefrontal rTMS in Major Depression: A THREE-D Study.
    Kaster TS; Downar J; Vila-Rodriguez F; Thorpe KE; Feffer K; Noda Y; Giacobbe P; Knyahnytska Y; Kennedy SH; Lam RW; Daskalakis ZJ; Blumberger DM
    Am J Psychiatry; 2019 May; 176(5):367-375. PubMed ID: 30764649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of Standard Sequential Bilateral Repetitive Transcranial Magnetic Stimulation vs Bilateral Theta Burst Stimulation in Older Adults With Depression: The FOUR-D Randomized Noninferiority Clinical Trial.
    Blumberger DM; Mulsant BH; Thorpe KE; McClintock SM; Konstantinou GN; Lee HH; Nestor SM; Noda Y; Rajji TK; Trevizol AP; Vila-Rodriguez F; Daskalakis ZJ; Downar J
    JAMA Psychiatry; 2022 Nov; 79(11):1065-1073. PubMed ID: 36129719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive Transcranial Magnetic Stimulation (5 and 10 Hz) With Modified Parameters in the Treatment of Resistant Unipolar and Bipolar Depression in a Private Practice Setting.
    Rachid F; Moeglin C; Sentissi O
    J Psychiatr Pract; 2017 Mar; 23(2):92-100. PubMed ID: 28291034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(4):1-232. PubMed ID: 34055112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness and acceptability of accelerated repetitive transcranial magnetic stimulation (rTMS) for treatment-resistant major depressive disorder: an open label trial.
    McGirr A; Van den Eynde F; Tovar-Perdomo S; Fleck MP; Berlim MT
    J Affect Disord; 2015 Mar; 173():216-20. PubMed ID: 25462419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurocognitive Effects of Repetitive Transcranial Magnetic Stimulation With a 2-Coil Device in Treatment-Resistant Major Depressive Disorder.
    Kavanaugh BC; Aaronson ST; Clarke GN; Holtzheimer PE; Johnson CW; McDonald WM; Schneider MB; Carpenter LL
    J ECT; 2018 Dec; 34(4):258-265. PubMed ID: 29613944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticomotor plasticity as a predictor of response to high frequency transcranial magnetic stimulation treatment for major depressive disorder.
    Hinchman CA; Fried PJ; Jannati A; Press DZ; Pascual-Leone A; Stern AP
    J Affect Disord; 2022 Apr; 303():114-122. PubMed ID: 35139416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extension of transcranial magnetic stimulation treatment for depression in non-responders: Results of a naturalistic study.
    Razafsha M; Barbour T; Uribe S; Behforuzi H; Camprodon JA
    J Psychiatr Res; 2023 Feb; 158():314-318. PubMed ID: 36628873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors in major depressive disorder: comparing responders and non-responders to Repetitive Transcranial Magnetic Stimulation (rTMS), a naturalistic retrospective chart review.
    Abo Aoun M; Meek BP; Clair L; Wikstrom S; Prasad B; Modirrousta M
    Psychiatry Clin Neurosci; 2023 Jan; 77(1):38-47. PubMed ID: 36207801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Repetitive transcranial magnetic stimulation for the treatment of major depressive disorder: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2004; 4(7):1-98. PubMed ID: 23074457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Add-on rTMS for the acute treatment of depressive symptoms is probably more effective in adolescents than in adults: Evidence from real-world clinical practice.
    Zhang T; Zhu J; Xu L; Tang X; Cui H; Wei Y; Wang Y; Hu Q; Qian Z; Liu X; Tang Y; Li C; Wang J
    Brain Stimul; 2019; 12(1):103-109. PubMed ID: 30237010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.